2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 9, 2004, Pages 901-905

  Ahrar, Kamran ^a   Newman, Robert A ^a   Pang, Jihai ^a   Vijjeswarapu, Mary K ^a   Wallace, Michael J ^a   Wright, Kenneth C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; MITOMYCIN;

ARTICLE; CALCULATION; CELL GROWTH; CELL LINE; CELL STRAIN HT29; CHEMOEMBOLIZATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DEGRADATION; DRUG EFFECT; DRUG POTENCY; ELECTROSPRAY MASS SPECTROMETRY; EXPOSURE; HEAT SENSITIVITY; HEATING; HUMAN; HUMAN CELL; IC 50; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TEMPERATURE DEPENDENCE;

EID: 4544222309     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000136829.36643.ED     Document Type: Article

References (14)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49:8-31.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745-750.
3. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434-1440.
4. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
5. Fong Y, Kemeny N, Lawrence TS. Cancer of the liver and biliary tree. In: Devita VTJ, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001; 1162-1203.
6. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-240.
7. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
8. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1739.
9. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
10. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217:119-126.
11. Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002; 13:1225-1232.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
13. Sargent JM. The use of the MTT assay to study drug resistance in fresh tumour samples. Recent Results Cancer Res 2003; 161:13-25.
14. Medical Subject Headings. In: US National Library of Medicine; 1999. Available at: http://www.nlm.nih.gov/mesh/meshhome.html. Accessed May 26, 1999.